Solubility enhancement of fexofenadine using self-nano emulsifying drug delivery system for improved biomimetic attributes
Annales Pharmaceutiques Françaises · 2024
DOI: 10.1016/j.pharma.2023.10.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annales Pharmaceutiques Françaises, 2024. Verfasst von Popat Mohite und 3 weiteren Autor:innen. Beteiligte Einrichtung: AETs St. John Institute of Pharmacy and Research, Palghar, Maharashtra, India. Electronic address: mohitepb@gmail.com. Hauptthemen laut MEDLINE: Drug Delivery Systems, Nanoparticles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: China Medical University, Taiwan, Chiang Mai University.
Abstract (Originalsprache)
BACKGROUND: Fexofenadine is a poorly water-soluble drug, which limit its bioavailability and ultimately therapeutic efficacy. Liquid self-nano emulsifying drug delivery system (L-SNEDDs) is an approach that can enhance the solubility of fexofenadine by increasing its surface area and reducing the particle size, which increases the rate and extent of drug dissolution. METHOD: In this investigation, L-SNEDDs of fexofenadine was made up using surfactants and co-surfactant. The SNEDDS formulation was optimized using a pseudo-ternary phase diagram and characterized. RESULTS: The optimized L-SNEDDS incorporated fexofenadine were thermodynamically stable and showed mean droplet size and zeta potential of 155nm and -18mV, respectively unaffected by the media pH. In addition, the viscosity, and refractive index were observed 18.4 and 1.49 cps, respectively for optimized L-SNEDDS fortified fexofenadine. The results of Fourier transform infrared spectroscopy revealed an insignificant interaction between the fexofenadine and excipients. A drug loading efficiency of 94.20% resulted with a complete in vitro drug release in 2h, compared with the pure drug, which demonstrate significant improvement in the efficacy. Moreover, these results signify that on further in vivo assessment L-SNEDDS fortified fexofenadine can indicate improvement in pharmacokinetic and clinical outcome. CONCLUSION: Thus, the investigation revealed that, the L-SNEDDs incorporated fexofenadine was most effective with a mixture of surfactant and co-surfactant with improved solubility intend to relieve pain associated with inflammation with single-dose oral administration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- AETs St. John Institute of Pharmacy and Research, Palghar, Maharashtra, India. Electronic address: mohitepb@gmail.com.
- MES's College of Pharmacy, Sonai, Ahmednagar, Maharashtra, India.
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, 50200 Chiang Mai Thailand; Office of Research Administration, Chiang Mai University, 50200 Chiang Mai Thailand.
- Shree S. K. Patel College of Pharmaceutical Education and Research, Ganpat University, Kherva, Gujarat 384012, India.
Förderung
- China Medical University, Taiwan
- Chiang Mai University
Zitieren
APA
Mohite, P., Joshi, A., Singh, S., & Prajapati, B. (2024). Solubility enhancement of fexofenadine using self-nano emulsifying drug delivery system for improved biomimetic attributes. Annales Pharmaceutiques Françaises. https://doi.org/10.1016/j.pharma.2023.10.003
Vancouver
Mohite P, Joshi A, Singh S, Prajapati B. Solubility enhancement of fexofenadine using self-nano emulsifying drug delivery system for improved biomimetic attributes. Annales Pharmaceutiques Françaises. 2024. doi:10.1016/j.pharma.2023.10.003
BibTeX
@article{Mohite2024,
author = {Mohite, Popat and Joshi, Anjali and Singh, Sudarshan and Prajapati, Bhupendra},
title = {Solubility enhancement of fexofenadine using self-nano emulsifying drug delivery system for improved biomimetic attributes},
journal = {Annales Pharmaceutiques Françaises},
year = {2024},
doi = {10.1016/j.pharma.2023.10.003}
}
EUVIMED